# FDA Inspection 1153328 - Stembanc Inc - September 23, 2021

Source: https://www.keypedia.com/records/fda_inspections/stembanc-inc/2bd2c3e3-9feb-499a-83ce-eeac16c8a341
Source feed: FDA_Inspections

> FDA Inspection 1153328 for Stembanc Inc on September 23, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1153328
- Company Name: Stembanc Inc
- Inspection Date: 2021-09-23
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1242190 - 2024-06-06](https://www.keypedia.com/records/fda_inspections/stembanc-inc/7a505376-1919-49f2-aaf0-8fb15814d61b)
- [FDA Inspection 1153328 - 2021-09-23](https://www.keypedia.com/records/fda_inspections/stembanc-inc/75c84b4c-1ae1-4f7a-9cca-d3e67bea54a8)
- [FDA Inspection 1153328 - 2021-09-23](https://www.keypedia.com/records/fda_inspections/stembanc-inc/93f8432d-adf9-454c-9536-33ed0dea0cd0)
- [FDA Inspection 862242 - 2014-02-12](https://www.keypedia.com/records/fda_inspections/stembanc-inc/05432b6a-b44b-4c03-b2c3-a50e23f7025e)
- [FDA Inspection 814359 - 2013-02-04](https://www.keypedia.com/records/fda_inspections/stembanc-inc/1c138f34-1dd3-4c20-920b-483c97e6c875)

Company: https://www.keypedia.com/companies/stembanc-inc/ad32a63d-5cde-422f-b60f-e7e1d3e81799

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d